Search

Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.

CMSC Abstracts Search Form (Titles and Authors only)

Search Accepted Abstracts
Sending

Search Results

Year ID Type Category Title Authors
2023 IMG13 Poster Imaging

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

Lynden Bajus, BS1, Kelly Leyden, MRes1 and Cristina Granziera, MD, PhD2, (1)Octave, Menlo Park, CA, (2)Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland

2023 IMG14 Poster Imaging

Cautions in Anisotropy: Thick Slices and Slice Gaps in 2D MR Acquisition Tarnish Volumetrics

Samuel W Remedios, BS1,2, Blake E Dewey, PhD3, Yuan Xue, PhD4, Lianrui Zuo, MSE4,5, Sandra D Cassard, ScD3, Carolyn Koch, MA3, Ann Fishman, MBA6, Jerry L Prince, PhD4, Ellen M. Mowry, MD, MCR3 and Scott D Newsome, DO, MSCS3, (1)Computer Science, Johns Hopkins University, Baltimore, MD, (2)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (5)National Institute on Aging, National Institutes of Health, Baltimore, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

2023 IMG15 Poster Imaging

Quantifying Contrast Differences Among MR Images Used in Clinical Studies

Savannah P Hays, BS1, Lianrui Zuo, MSE1,2, Blake E Dewey, PhD3, Samuel W Remedios, BS4,5, Yuan Xue, PhD1, Sandra D Cassard, ScD3, Carolyn Koch, MA3, Ann Fishman, MBA6, Aaron Carass, MS1, Peter A Calabresi, MD3, Jerry L Prince, PhD1, Ellen M. Mowry, MD, MCR3 and Scott D Newsome, DO, MSCS3, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (5)Computer Science, Johns Hopkins University, Baltimore, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

2023 IMG16 Poster Imaging

The Relationship between Protxx Wearable Sensor Data and White Matter Microstructure in People with Multiple Sclerosis

Sepideh Heydari, PhD1,2, Colleen Lacey, M.Sc.1, Kathryn Stewart-Good, RA1, Chantel Mayo, PhD3, John Ralston, PhD4 and Jodie R Gawryluk, Ph.D., R.Psych.1,2, (1)Psychology, University of Victoria, Victoria, BC, Canada, (2)Institute on Aging and Lifelong Health, Victoria, BC, Canada, (3)Neuropsychology, University of Manitoba, Winnipeg, MB, Canada, (4)Neursantys, Menlo Park, CA

2023 IMG17 Poster Imaging

Retinal Layer Thickness Comparison between the UK Biobank and a Multiple Sclerosis Dataset

Shuwen Wei, PhD1, Ji Hee Kim, PhD1, Yihao Liu, MSE1, Lianrui Zuo, MSE1,2, Shiv Saidha, MBBCh, MD, MRCPI3, Kathryn C. Fitzgerald, ScD3, Peter A Calabresi, MD3, Jerry L Prince, PhD1 and Aaron Carass, MS1, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

2023 IMG18 Poster Imaging

Synthesizing Missing MRI Sequences to Improve Processing Images in Multiple Sclerosis

Yuan Xue, PhD1, Blake E Dewey, PhD2, Lianrui Zuo, MSE1,3, Samuel W Remedios, BS4,5, Savannah P Hays, BS1, Sandra D Cassard, ScD2, Carolyn Koch, MA2, Ann Fishman, MBA6, Aaron Carass, MS1, Peter A Calabresi, MD2, Jerry L Prince, PhD1, Ellen M. Mowry, MD, MCR2 and Scott D Newsome, DO, MSCS2, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (3)National Institute on Aging, National Institutes of Health, Baltimore, MD, (4)Computer Science, Johns Hopkins University, Baltimore, MD, (5)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

2023 IMG19 Poster Imaging

Clinical and Radiologic Characteristics of Early Onset and Late Onset Adult Multiple Sclerosis

Murali Palathinkara, BS1, Abrahim N Razzak, BS1, Delaney Cairns, BS2 and Ahmed Z Obeidat, MD, Ph.D.1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Medical College of Wisconsin, Milwaukee, WI

2023 LB01 Poster Complementary and alternative therapies

Reduced Objective Disability in Relapsing-Remitting Multiple Sclerosis during a Dietary Intervention Trial: A Secondary Analysis of the Waves Trial

Landon J Crippes, BS1;Solange M Saxby, PhD, RDN2;Farnoosh Shemirani, PhD2;Linda M Rubenstein, PhD3;Patrick Ten Eyck, PhD4;Lucas J Carr, PhD5;Warren G Darling, PhD5;Karin F. Hoth, PhD6;John A Kamholz, MD, PhD7;Linda G Snetselaar, PhD, RDN3;Tyler J Titcomb, PhD, RDN2 and Terry L Wahls, MD*2, (1)Carver College of Medicine, The University of Iowa, Iowa City, IA, (2)Internal Medicine, University of Iowa, Iowa City, IA, (3)Epidemiology, University of Iowa, Iowa City, IA, (4)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (5)Department of Health and Human Physiology, University of Iowa, Iowa City, IA, (6)Department of Psychiatry, University of Iowa, Iowa City, IA, (7)Neurology, University of Iowa, Iowa City, IA

2023 LB02 Poster Disease-modifying therapy

Frexalimab, a CD40L Inhibitor, in Relapsing Multiple Sclerosis: Results from a Randomized Controlled Phase 2 Trial

Patrick Vermersch, MD, PhD1;Cristina Granziera, MD, PhD2,3;Yang Mao-Draayer, MD, PhD4;Gary Cutter, MS, PhD5;Oleksandr Kalbus, MD, PhD6;Ivan Staikov, MD, PhD7;Michal Dufek, PhD8;Stephane Saubadu, MD9;Raphael Bejuit, MD9;Philippe Truffinet, MD9;Erik Wallstroem, MD, PhD10 and Gavin Giovannoni, MD, PhD, FCP, FRCP, FRCPath*11, (1)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, (2)Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland, (3)Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, (4)Department of Neurology, Autoimmunity Center of Excellence, University of Michigan Medical Center, Michigan, MI, (5)Department of Biostatistics, UAB School of Public Health, Birmingham, AL, (6)Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, (7)Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, (8)1st Department of Neurology, St. Anne’s University Hospital, Brno, Czech Republic, (9)Sanofi, Chilly-Mazarin, France, (10)Sanofi, Cambridge, MA, (11)Queen Mary University of London, London, United Kingdom

2023 LB03 Poster Internet and information services

Clinical Simulation As a Novel Approach to Evaluate Digital Health Solutions: Floodlight MS Case Study

Jack Halligan, MB BCh BAO LRCP&SI, MBA*1;Luca Capezzuto, PhD2;Simon Dryden, PhD1;Saira Ghafur, Dr, MBChB, MRCP (resp), MSc1;Stanislas Hubeaux, MSc2;Agne Kazlauskaite, PhD2 and Riley Bove, MD3, (1)Prova Health, London, United Kingdom, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)UCSF Weill Institute for Neurosciences, San Francisco, CA

2023 LB04 Poster Neuropathology and pathogenesis

Systematic Review of Peripheral Nervous System Involvement in Multiple Sclerosis

Shitiz Sriwastava, MD*, UTHealth, Houston, TX;Suban Amatya, MBBS, Patan academy health science, Kathmandu, Nepal and Rajesh Gupta, MD, University of Texas at Houston, Houston, TX

2023 LB05 Poster Disease-modifying therapy

Lymphocyte Dynamics in Patients Who Were Treated with Dimethyl Fumarate for at Least 1 Year and Subsequently Switched to Diroximel Fumarate

Shauna M Gales, PA-C*1;Ahmed Z Obeidat, MD, PhD2;Andreina Neall, ARNP3;Kermit A Lloyd, MD4;Nicholas Belviso, PhD5;Seth Levin, MD5;Ivan Bozin, MD6;Jason P. Mendoza, PhD5;James B. Lewin, PharmD5 and Michael D Kornberg, MD PhD MS7, (1)Mellen Center, Cleveland Clinic Foundation, Cleveland, OH, (2)Neurology, Medical College of Wisconsin, Milwaukee, WI, (3)Orlando Health, Orlando, FL, (4)Riverside Neurology Specialists, Newport News, VA, (5)Biogen, Cambridge, MA, (6)Biogen, Baar, Switzerland, (7)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

2023 LB06 Poster Quality of life and outcomes

Patient-Reported Health Inequities Among Multiple Sclerosis Patients

Beth Schneider, BA*, Research, MyHealthTeam, San Francisco, CA;Chris Hardy, MS, Research, Publicis Health Media, New York, NY and Elizabeth Luce, BS, MBA, MyHealthTeam, San Francisco, CA

2023 LB07 Poster Disease-modifying therapy

Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A Menactrims Registry Based Study

Maya Zeineddine, PharmD, PHD Candidate*, Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates; Institute of Epidemiology and Tropical Neurology, Limoges University, Limoges, France and Bassem Yamout, MD, American University of Beirut Medical Center, Beirut, Lebanon

2023 LB08 Poster Neurophysiology; Neuropsychology and neuropsychiatry

Excitatory-Inhibitory Cortical (Im)Balance Predicts Disability in Multiple Sclerosis: A Transcranial Magnetic Stimulation Study

Arthur R. Chaves, PhD*, Health Sciences, University of Ottawa, Ottawa, ON, Canada;Sara Tremblay, PhD, Départment de psychoéducation et psychologie, Université du Québec en Outaouais, Gatineau, QC, Canada;Lara A. Pilutti, PhD, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada;Michelle Ploughman, PhD, Physical Medicine & Rehabilitation, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NF, Canada and CEPL, Recovery and Performance Lab, and NEST Lab

2023 LB09 Poster Disease-modifying therapy

Real-World Satisfaction and Experience with Injection and Autoinjector Device for Ofatumumab Indicated for Multiple Sclerosis

Amy Perrin Ross, APN, MSN, CNRN, MSCN*1;Jacqueline Nicholas, MD, MPH2;Ming-Hui Tai, PhD3;Stephen Yeung, MD3;Nazneen Fatima Shaikh, PhD4;Helen Chen, BS4;Mariana Fernandes, MS4 and Kevin Hawkins, PhD4, (1)Neuroscience Nurse Consultant, Oak Brook, IL, (2)OhioHealth Multiple Sclerosis Center, 3535 Olentangy River Rd, Suite 1501, Columbus, OH, (3)Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, (4)Real World Solutions, IQVIA, 2400 Ellis Road Durham, NC

2023 LB10 Poster Disease-modifying therapy

Ofatumumab Effectiveness and Safety in Relapsing Multiple Sclerosis Patients with Breakthrough Disease on Oral Fumarates or Fingolimod: Artios Interim Analysis

Riley Bove, MD*1;Matthew Craner, MB ChB FRCP PhD2;Dawn Langdon, PhD3;Daniel Sienkiewicz, PhD4;Javier Ricart, PhD5;Soudeh Ansari, PhD6;Sophie Arnould, MSc7;Ibolya Boer, MD7 and Tobias Derfuss, MD8, (1)University of California San Francisco, San Francisco, CA, (2)John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, (3)Royal Holloway, University of London, London, United Kingdom, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Novartis Farmacéutica, Barcelona, Spain, (6)Novartis Institutes for Biomedical Research, Cambridge, MA, (7)Novartis Pharma AG, Basel, Switzerland, (8)Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland

2023 LB11 Poster Disease-modifying therapy

Real-World Outcomes and Treatments for Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Dusan Stefoski, MD1;John Foley, MD*2;Cortnee Roman, MSN, FNP-BC2;Karen Smirnakis, MPH3;Kerry McCarthy, BSN3;Robin L. Avila, PhD3;Thuy Luu, MD3;Aaron Galluzzi, PhD4;Liesel Dsilva, PhD3 and Jennifer Lyons, MD3, (1)Rush Medical College, Chicago, IL, (2)Rocky Mountain MS Clinic, Salt Lake City, UT, (3)Biogen, Cambridge, MA, (4)Cytel, Cambridge, MA

2023 LB12 Poster Quality of life and outcomes

Multiple Sclerosis: Importance of Patient-Centric Education on Healthcare Communications and Decisions

Elaine Rudell, CHCP1;Michele F. Ingram, BS1;Alicia Zambri, NA1;Tarjani Agrawal, PhD1;Olga Syritsyna, MD2;Nancy McLinskey, MD2;Patricia Melville, ANP-BC, MSCN3;Brant Oliver, PhD, MS, MPH, APRN-BC, MSCN4 and Patricia K. Coyle, MD*2, (1)Projects In Knowledge Powered by Kaplan, Short Hills, NJ, (2)MS Comprehensive Care Center, Stony Brook Neurosciences Institute, Stony Brook, NY, (3)Dept. of Neurology, MS Comprehensive Care Center, SUNY at Stony Brook, Stony Brook, NY, (4)Chronic Health Improvement Research Program at Dartmouth Health, Hanover, NH

2023 LB13 Poster Case Reports/Case Series

Consultative, Proactive Physical Therapy in Early Multiple Sclerosis

Monica Hendricksen, PT, DPT1;Jake Boyer, PT, DPT1;Kristen Hohl, PT, DPT, NCS1;Edith Graham, MD2;Roumen Balabanov, MD3;Miriam Rafferty, DPT, PhD1 and Dominique Kinnett-Hopkins, PhD*4, (1)Shirley Ryan AbilityLab, Chicago, IL, (2)Northwestern University, Chicago, IL, (3)Rush University Multiple Sclerosis Center, Chicago, IL, (4)School of Kinesiology, University of Michigan, Ann Arbor, MI

2023 LB14 Poster Disease-modifying therapy

SARS-CoV-2 Vaccine Response in RMS Patients Treated with Ozanimod and Other DMTs: 48-Weeks Results from the Z-CAN Trial

Daniel Kantor, MD*, Center for Global Health, University of Pennsylvania, Philadelphia, PA

2023 LB15 Poster Disease-modifying therapy

Real-World Persistence of Ofatumumab Vs. Oral Disease Modifying Therapies in Patients with Multiple Sclerosis

Magdaliz Gorritz, MPH1;Chi-Chang Chen, PhD1;Rifat Tuly, MPH1;Yifan Gu, MS1;Abhijit Gadkari, PhD2;Brandon Brown, PharmD2;Qiujun Shao, PhD2 and Carrie M Hersh, DO, MS, FAAN*3, (1)IQVIA, Plymouth Meeting, PA, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

2023 LB16 Poster Disease-modifying therapy

Cladribine Tablets after Treatment with Natalizumab (CLADRINA) Trial – Clinical Analysis

Peter Sguigna, MD*1;Annette F Okai, MD2;Jeffrey Kaplan, MD3;Kyle Blackburn, MD1;Lauren Tardo, MD1;Lori A Lebson, PhD4;Julie Korich, PhD4;Navid Manouchehri, MD1;Rehana Z Hussain, MSc1 and Olaf Stuve, MD, PhD5, (1)University of Texas Southwestern Medical Center, Dallas, TX, (2)North Texas Institute of Neurology & Headache, Plano, TX, (3)Kansas City Multiple Sclerosis and Headache Center, Overland Park, KS, (4)EMD Serono, Rockland, MA, (5)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

2023 MDC01 Poster Multidisciplinary care

An Innovative Multidisciplinary Approach to Fatigue Management Utilizing the Shared Medical Appointment Model

Alexa Kane, PsyD, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

2023 MDC02 Poster Multidisciplinary care

A Tale of Two Clinics: Providing Targeted and Efficient Spasticity Management and Virtual Neurology Care for People with Advanced Multiple Sclerosis

Alexander Burnham, MS, CCC-SLP, MSCS1, Stephen Koelbel, MD2, Maria K Houtchens, MD3, Jonathan Zurawski, MD4, Kristy Ford, MS, OTR/L5, Lynn Stazzone, NP6 and John M. Sullivan, PA-C4, (1)Rehabilitation Services, The Boston Home, Boston, MA, (2)Spasticity Management, The Boston Home, Boston, MA, (3)Neurology, Brigham Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (4)Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA, (5)Admissions, The Boston Home, Boston, MA, (6)Brigham and Women’s Hospital, Boston, MA

2023 MDC03W Poster Multidisciplinary care

Prescription for Wellness: Pilot Study for MS Patients to Improve Metabolic Profile and MS Quality of Life Parameters

Asya Wallach, MD1, Reg Grant, CAT(C), CSCS, RSCC*E2, Jeffrey Portnoy, PhD2, Gautam Bhasin, PsyD2, Thomas Birch, MD2, Brianne Etter, PT, DPT, CLT2, Deborah Bessen, RD2, Tracee Yablon Brenner, RD2, Matthew Hoeppner, PA-C2, Jason Kavountzis, PT, MAS, OCS2, Maxwell Edmiston, MSA, CSCS2 and Mary Ann Picone, MD1, (1)Holy Name MS Center, Teaneck, NJ, (2)Holy Name, Teaneck, NJ

2023 MDC05 Poster Multidisciplinary care

Using a Standardized Quality Improvement Process to Incorporate Patient-Reported Symptom Data in Routine Clinical Care

Deborah M Miller, PhD, LISW1, Benjamin M Pannell, MS2, Nichole Davis, BA3, Alexa Kane, PsyD4, Desiree Chizmadia, MSN5, Hilary Young, PA-C5, Deja Rose, M.D.6, Kasandra Weigland, BA7, Stephanie Covert, DPT8 and Robert A. Bermel, MD9, (1)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)NA, Cleveland, OH, (3)OR, Cleveland Clinic, Cleveland, OH, (4)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Mellen Center, Cleveland Clinic, Cleveland, OH, (6)Neurology, Emory University, Atlanta, GA, (7)Workforce Strategies Administration, Cleveland Clinic, Cleveland, OH, (8)Neurological Institute, Cleveland Clinic, Cleveland, OH, (9)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH

2023 MDC06 Poster Multidisciplinary care

Implementing a Community-Based Virtual Tool to Characterize Sidewalk Accessibility in a Northern New Jersey (NJ) Town

Kie Fujii, BA1,2, Katrina Ma, N/A3, Chu Li, MS3, Michael Saugstad, N/A3, Lisa Stolarz, MA2, Michael I Starr, MBA2, Florian P Thomas, MD, PhD1,2,4 and Jon Froehlich, PhD3, (1)Department of Neurology, Hackensack Meridian School of Medicine, Nutley, NJ, (2)National MS Society – NJM Community Council, Bergen County, NJ, (3)Allen School of Computer Science & Engineering, University of Washington, Seattle, WA, (4)Department of Neurology & Neuroscience Instiutute, Hackensack University Medical Center, Hackensack, NJ

2023 MDC07W Poster Multidisciplinary care

The Role of Behavioral Medicine in Inpatient Care of MS and AE

Grace E Tworek, Psy.D., The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

2023 MDC08 Poster Multidisciplinary care

Impact to Immunization Completion Rates By Incorporating Clinical Pharmacists on a Multiple Sclerosis Care Team

Nicole Hahn, PharmD, BCACP1, Shilpa Klocke, PharmD, BCPS1, Thomas Delate, PhD, MS2 and Samuel Cohn, MD1, (1)Neurology, Kaiser Permanente Colorado, Denver, CO, (2)National Pharmacy Services, Kaiser Permanente, Aurora, CO

2023 MDC09 Poster Multidisciplinary care

Patterns of Multiple Sclerosis Presentation to the Emergency Department

Alaa Maglan, MBBS1, Osama Khojah, MBBS2, Faris Allaf, MBBS3, Saeed Alamoudi, MBBS4, Meral Altayeb, MBBS3, Rawaf Alsharif, MBBS3, Mohamed Eldigire Ahmed, MBBS5 and Seraj Makkawi, MBBS3, (1)College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, (2)Department of Medicine, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia, (3)King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, (4)King Khalid Eye Specialist Hospital, Jeddah, Saudi Arabia, (5)King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

2023 MOC02 Poster Methods of Care

Seropositive Mog Antibody-Associated Syndrome That Presented As Clippers-like Brainstem Syndrome, a Case Presentation and Literature Review

Eric Yeager, MD, Neurology, UT Health San Antonio, San Antonio, TX, Xavier Carrier, MD, Radiology, UT Health San Antonio, san antonio, TX, Mathew Roberts, MD, Neurology, UT Health San Antonio, san antonio, TX and Tania Reyna, MD, Neurology, University of Texas Health San Antonio, San Antonio, TX

2023 MOC03 Poster Methods of Care

Combined Central and Peripheral Demyelination: Clinical and Immunologic Aspects

Ganiru O Anunike, BA, Vikhyathi Pallerla, BS, MSBS, Boyd M Koffman, M.D., Ph.D and Sabeena I Malik, MD, Neurology, University of Toledo College of Medicine and Life Sciences, Toledo, OH

2023 MOC04 Poster Methods of Care

Detection of Silent UTI – a Case Study

Heather Hua, RN, MSN, MSCN1, Danielle Siniscalchi, MBA1, Deanna Power, RN, MSCN1 and Jennifer Graves, MD, PhD, MAS2, (1)Octave, Menlo Park, CA, (2)University of California San Diego, San Diego, CA

2023 MOC05 Poster Methods of Care

Trigeminal Neuralgia in Multiple Sclerosis: Association with Demyelination and Progression

Hossein Mousavi, MD1, John W. Lindsey, MD2, Rajesh Gupta, MD3, Jerry S. Wolinsky, MD4 and John A Lincoln, MD3, (1)Neurology, University of Texas Health Center at Houston, Houston, TX, (2)Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX, (3)University of Texas at Houston, Houston, TX, (4)Test Department, Test Affiliation, Hackensack, NJ

2023 MOC06 Poster Methods of Care

Subcutaneous Granulomata and Calcifications Secondary to Interferon-Beta-1a Injections Decades Prior in a Patient with Multiple Sclerosis: A Case Report and Literature Review

Mara Bahri, MSc, The Ohio State University College of Medicine, Columbus, OH and Kristi Epstein, APRN-CNP, Department of Neurology, The Ohio State University, Columbus, OH

2023 MOC07 Poster Methods of Care

Implementing a Multidisciplinary Approach for Older Adults with Multiple Sclerosis: Development of the Aging with MS Clinic

Mara Bahri, MSc1, Brooke Gaul, PT, DPT2, Claire Thieneman, PharmD3, Sarah Grim, LISW-S4, Kristi Epstein, APRN-CNP4, Rolanda Robinson, PhD4, Sarita Maturu, DO4 and Yinan Zhang, MD4, (1)The Ohio State University College of Medicine, Columbus, OH, (2)Outpatient Rehabilitation, Neurology, The Ohio State University, Columbus, OH, (3)The Ohio State University, Columbus, OH, (4)Department of Neurology, The Ohio State University, Columbus, OH

2023 MOC08 Poster Methods of Care

The Pearls and Pitfalls of the Inpatient-Outpatient Transition in Newly Diagnosed Neuromyelitis Optica Spectrum Disorder

Ross C Crandall, MD, Neurology Residency Program, University of Colorado School of Medicine, Aurora, CO, Aaron Carlson, MD, Neurology, University of Colorado, Anschutz Medical Campus, Denver, CO, Amanda L Piquet, MD, Neurology, University of Colorado School of Medicine, Aurora, CO and Kavita V Nair, PhD, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO

2023 MOC09 Poster Methods of Care

An Unusual Case of Bilateral Optic Neuropathy and Encephalopathy

Samantha N Roman, MD and Scott D Newsome, DO, MSCS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

2023 MOC10 Poster Methods of Care

Ocrelizumab-Induced Psoriasis in a Patient with Relapsing-Remitting Multiple Sclerosis

Sara Esmaeili, Research Fellow, Neurology, University of Cincinnati, Cincinnati, OH and Aram Zabeti, MD, Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH